Patent Application
20130304102
1. Field of the Invention
The present invention relates generally to medical apparatus and methods and methods. More particularly, the present invention relates to apparatus and methods for constraining a portion of a blood vessel wall to enhance the response of a stretch receptor in an adjacent region of the wall.
Hypertension is a medical condition characterized by a constant state of elevated blood pressure and can result from a number of underlying factors, including genetics, obesity, diet, and the like. When diagnosed, hypertension is most commonly treated by changes in diet, exercise, and pharmaceutical intervention. More recently, it has been proposed to treat hypertension and related conditions by stimulating or modulating certain stretch receptors, referred to as baroreceptors, in the patient's vasculature. Those receptors are located in the walls of certain blood vessels, such as the carotid arteries and the aortic arch. It has been found that stimulating the baroreceptors and/or the nerves connected to the baroreceptors, can reduce a patient's blood pressure in a clinically effective manner, even when those patients have been resistant to other hypertension treatments.
While a number of these treatments appear to be quite effective in pre-clinical and clinical studies, it would be desirable to provide additional and alternative methods and apparatus for effecting or modulating baroreceptors and other stretch receptors in a clinically effective manner, particularly for the treatment of hypertension and related conditions. At least some of these objectives will be met by the inventions described below.
2. Description of the Background Art
Implantable devices for effecting baroreceptor stimulation are described in US 2008/0033501; US 2001/0077729; US 2011/0178416; 2011/0213408; and 2011/0230953. See also U.S. Pat. No. 6,178,349; U.S. Pat. No. 6,522,926; U.S. Pat. No. 6,850,801; U.S. Pat. No. 7,158,832; U.S. Pat. No. 7,499,747; U.S. Pat. No. 7,499,742; and U.S. Pat. No. 7,502,650.
The present invention provides additional and alternative methods and apparatus for stimulating stretch receptors, such as baroreceptors, in a patient's vascular wall. The methods and apparatus are particularly useful for treating hypertension and related conditions, such as congestive heart failure, renal disease, and the like, and may be used as a sole treatment or in combination with other treatments, including pharmaceuticals, lifestyle changes, and other methods and techniques for stimulating or modulating the baroreceptor or other stretch receptor responses.
The present invention differs at least in part from prior methods and apparatus in that an intervention in the vasculature occurs at a region away from the stretch receptor itself. In particular, by constraining portions of a blood vessel wall upstream or downstream of a target stretch receptor, a volumetric or expansion response of the stretch receptor can be amplified or magnified in a manner which will increase the stretch receptor signal which is transmitted by the associated nerves. By “amplification” or “magnification”, it is meant that the signal in response to an increase (or decrease) in pressure within the blood vessel will be greater (or lesser) in response to the intervention than in the absence of the intervention.
In a most straightforward manner, the present invention provides a passive restraint of the blood vessel wall upstream and/or downstream of the target stretch receptor, where the restraint inhibits or prevents expansion and/or contraction of that region of the blood vessel wall. Such constraint, in turn, amplifies or increases the pressure response in an adjacent stretch receptor region of the blood vessel wall which in turn increases the signal generated by the receptor.
In other implementations of the present invention, the restraint could be active. For example, a circumferential or peripheral restraint placed over and/or within the blood vessel can be adjusted in real time after implantation in order to increase, decrease, or provide for feedback control of the stretch receptor signal over time. For example, after implantation, the treating physician can monitor the patient's blood vessel and, if necessary, remotely adjust the degree of constraint provided by the implant using radio frequency or other known techniques for reconfiguring implants. Alternatively, such adjustment could be implemented by minimally invasive surgical techniques.
As a still further alternative, the adjustment of constraint could be performed in response to periodic or real time monitoring of the patient's blood pressure. An implanted or external controller can be configured to receive a signal representative of the patient's blood pressure and to provide a control signal output which can adjust the previously implanted blood vessel wall constraint to provide a desired change in the constraint and resulting change in the amplification of the stretch receptor response.
In a first aspect of the present invention, a method for stimulating a stretch receptor in a vascular wall comprises identifying a region in a patient's vasculature proximate a target stretch receptor, for example, a baroreceptor in a carotid artery wall. A portion of the blood vessel wall upstream and and/or downstream of the target stretch receptor is then constrained in a manner such that the volume displacement during systole and/or diastole is inhibited in the constrained portion and increased in the target region relative to volume displacement in the absence of such constraining
In specific embodiments, the method may further comprise selecting a patient diagnosed with at least one of hypertension, congestive heart failure, renal disease or the like. The stretch receptor will typically comprise a baroreceptor, which is disposed for example in a carotid artery, an aortic arch, or the like. Constraining typically comprises placing a circumferential restraint over an exterior of the blood vessel and/or along or within an internal wall of the blood vessel. The constraint may be elastic, inelastic, or have characteristics intermediate elastic and inelastic. The constraint may be a simple ring or a band which is placed over or within the blood vessel wall, but could be more complex and have regions with different mechanical properties and/or different mechanisms for adjusting the circumferential length or elastic properties. The constraint will typically have an axial length in the range from 0.5 mm to 5 mm, usually from 1 mm to 3 mm, diameter or width in the range from 3 mm to 30 mm, usually from 6 mm to 20 mm. While one constraint will usually be sufficient, in some instances it may be desirable to place two, three, four or even more constraints at locations upstream and/or downstream of the stretch receptor and external and/or internal to the blood vessel wall.
In a second aspect, the present invention provides apparatus for stimulating a stretch receptor. The apparatus comprises a blood vessel wall expansion constraint adapted to be positioned over or within a portion of a blood vessel wall upstream or downstream of a stretch receptor in said blood vessel wall. The expansion constraint typically comprises a circumferential restraint which is adapted to circumscribe the external wall of the blood vessel and/or be secured to an internal wall of the blood vessel immediately upstream or downstream of the target stretch receptor. These specific characteristics of the constraint have been described above in connection with the methods of the present invention.
Suitable materials for the constraint include metals, polymers, meshes, and the like. The materials will be selected to be compatible and suitable for long term implantation with or surrounding the vasculature.
Referring to
As illustrated, the external cuff 10 and internal cuff 12 are simple cylindrical tubes which are placed on or in the blood vessel BV. The manner of placement will, of course, dictate further structure for the constraints 10 and 12. For example, the external restraint 10 will typically be introduced through open surgical or minimally invasive techniques and will have to be wrapped around the outer wall of the blood vessel. In such instances, usually at least one seam or joint will be needed so that the constraint can be secured after it has been wrapped around the blood vessel. The internal constraint 12, in contrast, will most typically be introduced through an endovascular technique and may be delivered by balloon expansion, self-expansion, or the like. Usually, the internal constraint 12 will have means for embedding the constraint or attaching it to the internal wall of the blood vessel in order to inhibit expansion in response to an increase in pressure within the blood vessel. Techniques for attaching an internal scaffold or constraint to a wall of the blood vessel are known, for example, in connection with vascular grafts which are used, for example, in treatment of aortic abdominal aneurisms. Specific constructions of the external constraint 10 and internal constraint 12 may vary widely within the scope of the present invention so long as they provide for the inhibition or constraint of expansion of the covered wall relative to the unconstrained baroreceptor BR region of the wall.
An increase or amplification of the expansion of the baroreceptor BR as a result of the constraint 10 and 12 is illustrated in
Referring now to
This application claims the benefit of U.S. Provisional Application No. 61/644,911 (Attorney Docket No. 41594-705.101), filed May 9, 2012, the entire content of which is incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 61644911 | May 2012 | US |
